Opinion: The NIH is in danger of losing its edge in creating biomedical innovations
In Ernest Hemingway’s “The Snows of Kilimanjaro,” the protagonist dies from an infection after scratching his leg on a thorn. That was in 1936, before the introduction of penicillin. It’s hard to imagine a world in which every cut had the potential to be fatal, but that’s the world our grandparents lived in. Thanks to decades of truly amazing biomedical research, we live in a much safer world today. What’s equally exciting is that yesterday’s triumphs may pale beside the promise of tomorrow’s breakthroughs — if pressures on research funding don’t threaten the future of biomedical research.
For generations, America has been the world leader in biomedical research innovation. Lately, though, it has been losing its preeminence in discovery to other countries. This not only threatens the creation of new therapies but also imperils an industry that supports more than 300,000 jobs. Declining levels of federal funding for biomedical research, along with inefficient allocation of funds by the National Institutes of Health, are jeopardizing innovation.
At the same time, universities and nonprofit research institutes are experiencing funding cuts at the state level. In some instances, private philanthropy and disease-specific foundations have increased funding for biomedical research, but this is but a small piece of the pie that does not make up for the federal funding shortfall. Charitable
You’re reading a preview, subscribe to read more.
Start your free 30 days